BNGO News and Press, Bionano Genomics Inc. From 08/16/23

SAN DIEGO, Aug. 16, 2023 (GLOBE NEWSWIRE) -- Bionano Laboratories, a laboratory services business of Bionano Genomics, Inc. (Nasdaq: BNGO), today announced that it has received Laboratory Accreditation from the College of American Pathologists (CAP) for its Clinical Laboratory Improvement Amendme...

2023-08-14 18:17:22 ET A big change in the C-suite was behind the steep fall in Bionano Genomics ' (NASDAQ: BNGO) share price on Monday. Following the biotech's announcement that its CFO is stepping down, investors traded out of the stock to the point where it closed the day more th...

2023-08-14 14:06:16 ET More on Bionano Genomics Bionano Genomics, Inc. ( BNGO ) Presents at Canaccord Genuity 43rd Annual Growth Conference (Transcript) Bionano Genomics, Inc. ( BNGO ) Q2 2023 Earnings Call Transcript Bionano Genomics: A Noble Cause But A Bad...

SAN DIEGO, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Gülsen Kama will serve as its next Chief Financial Officer (CFO), effective September 11, 2023. Christopher Stewart, who held the position of CFO since September 2020, will stay ...

Dr. Alka Chaubey, chief medical officer at Bionano, will host a sponsored vendor panel presentation on the integration of OGM for clinical research in cancer, featuring cancer genomics experts Dr. Ravindra Kolhe, Augusta University, Dr. Yassmine Akkari, Nationwide Children’s Hospital,...

2023-08-11 07:28:08 ET Bionano Genomics, Inc. (BNGO) Canaccord Genuity 43rd Annual Growth Conference August 10, 2023 11:30 AM ET Company Participants Erik Holmlin - President and Chief Executive Officer Conference Call Participants Kyle Mikson - Canaccord Gen...

2023-08-09 20:30:31 ET Image source: The Motley Fool. Bionano Genomics (NASDAQ: BNGO) Q2 2023 Earnings Call Aug 09, 2023 , 4:30 p.m. ET Operator Continue reading For further details see: Bionano Genomics (BNGO) Q2 2023 Earnings Call Trans...

2023-08-09 19:19:02 ET Bionano Genomics, Inc. (BNGO) Q2 2023 Earnings Conference Call August 09, 2023, 04:30 PM ET Company Participants David Holmes - IR Erik Holmlin - CEO Chris Stewart - CFO Conference Call Participants Jason McCarthy - Maxim Group ...

2023-08-09 16:04:41 ET Bionano Genomics press release ( NASDAQ: BNGO ): Q2 net loss of $38.91M Revenue of $8.7M (+30.4% Y/Y) beats by $0.4M . Cash, cash equivalents, and available-for-sale securities were $77.1 million as of June 30, 2023, compared to cash, cash eq...

Q2 2023 revenue was $8.7 million, which represents a 30% increase over Q2 2022 Installed base of Saphyr ® systems totaled 281 as of June 30, 2023, which represents a 43% increase over Q2 2022 Sold 7,062 nanochannel array flowcells as of June 30, 2023, which represents a 108% ...